Heart, Lung and Circulation
Volume 17, Issue 6 , Pages 463-467, December 2008

Establishment of an Australian National Genetic Heart Disease Registry

  • Jodie Ingles

      Affiliations

    • Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Sydney, Australia
    • Department of Cardiology, Royal Brisbane and Women's Hospital, Brisbane, Australia
  • ,
  • Julie McGaughran

      Affiliations

    • Genetic Health QLD, Royal Children's Hospital, Brisbane, Australia
    • Department of Medicine, University of Queensland, Brisbane, Australia
  • ,
  • Jitendra Vohra

      Affiliations

    • Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia
  • ,
  • Robert G. Weintraub

      Affiliations

    • Department of Cardiology, Royal Children's Hospital, Melbourne, Australia
  • ,
  • Andrew Davis

      Affiliations

    • Department of Cardiology, Royal Children's Hospital, Melbourne, Australia
  • ,
  • John Atherton

      Affiliations

    • Department of Cardiology, Royal Brisbane and Women's Hospital, Brisbane, Australia
    • Department of Medicine, University of Queensland, Brisbane, Australia
  • ,
  • Christopher Semsarian

      Affiliations

    • Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Sydney, Australia
    • Central Clinical School, University of Sydney, Australia
    • Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia
    • Corresponding Author InformationCorresponding author at: Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Locked Bag 6, Newtown, NSW 2042, Australia. Tel.: +61 2 9565 6195; fax: +61 2 9565 6101.

Received 17 December 2007; received in revised form 3 April 2008; accepted 7 May 2008.

A National Genetic Heart Disease Registry has recently been established, with the aim to enrol every family in Australia with a genetically determined cardiomyopathy or primary arrhythmic disorder. The Registry seeks to further our understanding of the impact and burden of disease in this population; increase awareness and provide education to health professionals and families; and establish a large cardiac genetic cohort as a resource for approved research studies. The Registry is currently recruiting families with inherited cardiomyopathies (e.g. hypertrophic cardiomyopathy) and primary arrhythmogenic disorders (e.g. long QT syndrome), with scope to expand this in the future. Affected individuals, as well as their first-degree (at-risk) family members are eligible to enrol. Participants are currently being recruited from cardiac genetics clinics in approved recruitment sites and hope to expand to other Australian centres including general cardiology practice in the future. A significant focus of the Registry is to improve understanding and create awareness of inherited heart diseases, which includes ensuring families are aware of genetic testing options and current clinical screening recommendations for at-risk family members. A Registry Advisory Committee has been established under the NHMRC Guidelines, and includes a representative from each major recruitment centre. This committee approves all decisions relating to the Registry including approval of research studies. A National Genetic Heart Disease Registry will provide a valuable resource to further our knowledge of the clinical and genetic aspects of these diseases. Since most of the current data about the prevalence, natural history and outcomes of genetic heart diseases has emanated from the United States and Europe, characterising these Australian populations will be of significant benefit, allowing for more informed and specific health care planning and resource provision.

Keywords: Genetic heart disease, Registry, Families, Education, Research

 

PII: S1443-9506(08)00812-3

doi:10.1016/j.hlc.2008.05.603

Heart, Lung and Circulation
Volume 17, Issue 6 , Pages 463-467, December 2008